Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Heise

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Gene Therapy|April 21, 2001
Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trialS Mulvihill, R Warren, A Venook, et al.
Gastroenterology|June 1, 1991
Human immunodeficiency virus infection of enterocytes and mononuclear cells in human jejunal mucosaC Heise, S Dandekar, P Kumar, et al.
Journal of Hypertension|July 1, 1997
Effects of chronic hormone replacement on the renin-angiotensin system in cynomolgus monkeysK B Brosnihan, D Weddle, M S Anthony, et al.
Journal of Trace Elements and Electrolytes in Health and Disease|December 1, 1988
Serum and urinary magnesium, calcium and copper levels in insulin-dependent diabetic womenR G Smith, C C Heise, J C King, et al.
Nature Medicine|June 1, 1997
ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agentsC Heise, A Sampson-Johannes, A Williams, et al.
Nature Medicine|October 4, 2000
An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacyC Heise, T Hermiston, L Johnson, et al.
Journal of Orthopaedic Trauma|January 1, 1997
Intraoperative monitoring of motor pathways during operative fixation of acute acetabular fracturesD L Helfet, N Anand, A L Malkani, et al.
Anti-Cancer Drugs|March 27, 2002
Efficient induction of apoptosis by ONYX-015 adenovirus in human colon cancer cell lines regardless of p53 statusT Petit, K K Davidson, C Cerna, et al.
Cancer Research|March 23, 2000
In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapyK R Rogulski, S O Freytag, K Zhang, et al.
Oncogene|October 27, 1998
PTEN/MMAC1 is infrequently mutated in pT2 and pT3 carcinomas of the prostateJ T Dong, T W Sipe, E R Hyytinen, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Gene Therapy|April 21, 2001
Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trialS Mulvihill, R Warren, A Venook, et al.
Gastroenterology|June 1, 1991
Human immunodeficiency virus infection of enterocytes and mononuclear cells in human jejunal mucosaC Heise, S Dandekar, P Kumar, et al.
Journal of Hypertension|July 1, 1997
Effects of chronic hormone replacement on the renin-angiotensin system in cynomolgus monkeysK B Brosnihan, D Weddle, M S Anthony, et al.
Journal of Trace Elements and Electrolytes in Health and Disease|December 1, 1988
Serum and urinary magnesium, calcium and copper levels in insulin-dependent diabetic womenR G Smith, C C Heise, J C King, et al.
Nature Medicine|June 1, 1997
ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agentsC Heise, A Sampson-Johannes, A Williams, et al.
Nature Medicine|October 4, 2000
An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacyC Heise, T Hermiston, L Johnson, et al.
Journal of Orthopaedic Trauma|January 1, 1997
Intraoperative monitoring of motor pathways during operative fixation of acute acetabular fracturesD L Helfet, N Anand, A L Malkani, et al.
Anti-Cancer Drugs|March 27, 2002
Efficient induction of apoptosis by ONYX-015 adenovirus in human colon cancer cell lines regardless of p53 statusT Petit, K K Davidson, C Cerna, et al.
Cancer Research|March 23, 2000
In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapyK R Rogulski, S O Freytag, K Zhang, et al.
Oncogene|October 27, 1998
PTEN/MMAC1 is infrequently mutated in pT2 and pT3 carcinomas of the prostateJ T Dong, T W Sipe, E R Hyytinen, et al.
Pageof 4